Tonix Pharmaceutics Holdings Inc. (TNXP) stock gains during current market. What’s driving it high?
Tonix Pharmaceuticals Holdings Inc. (TNXP) stock gains by 2.81% in the current market trading session. Tonix is a clinical-stage biopharmaceutical business dedicated on finding, licensing, purchasing, and developing small molecules and biologics to cure, prevent, and relieve human illness. Tonix’s portfolio is largely made up of pharmaceutical candidates for the central nervous system and immunology. […]
What’s Driving Tonix Pharmaceuticals (TXNP) Stock Higher
Just before the start of the regular session today, Tonix Pharmaceuticals Holding Corp. (TNXP) stock has been trading premarket at a rise of 6.75% to $1.74. The clinical-stage biopharmaceutical company this morning announced the licensing of technology for treating Prader-Willi syndrome. Get the hottest stocks to trade every day before the market opens 100% free. […]
